Lymphadenectomy for papillary thyroid cancer: Changes in practice over four decades
Fausto Palazzo(Hammersmith Hospital), Leigh Delbridge(The University of Sydney), Jessica E. Gosnell(The University of Texas MD Anderson Cancer Center), Mark Sywak(Royal North Shore Hospital), Stan B. Sidhu(Royal North Shore Hospital), Robert Savio, T. S. Reeve(The University of Sydney), Bruce Robinson(University of Michigan)
Cited by 54
Related Papers
Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers
|New England Journal of Medicine|2020|766
Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
|Journal of Clinical Oncology|2010|517
Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer
|Surgery|2006|379